These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

551 related items for PubMed ID: 20565761

  • 1. Promoter- and cell-specific epigenetic regulation of CD44, Cyclin D2, GLIPR1 and PTEN by methyl-CpG binding proteins and histone modifications.
    Müller I, Wischnewski F, Pantel K, Schwarzenbach H.
    BMC Cancer; 2010 Jun 17; 10():297. PubMed ID: 20565761
    [Abstract] [Full Text] [Related]

  • 2. Selective association of the methyl-CpG binding protein MBD2 with the silent p14/p16 locus in human neoplasia.
    Magdinier F, Wolffe AP.
    Proc Natl Acad Sci U S A; 2001 Apr 24; 98(9):4990-5. PubMed ID: 11309512
    [Abstract] [Full Text] [Related]

  • 3. hMLH1 promoter methylation and silencing in primary endometrial cancers are associated with specific alterations in MBDs occupancy and histone modifications.
    Xiong Y, Dowdy SC, Eberhardt NL, Podratz KC, Jiang SW.
    Gynecol Oncol; 2006 Oct 24; 103(1):321-8. PubMed ID: 16701802
    [Abstract] [Full Text] [Related]

  • 4. CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2.
    Pulukuri SM, Rao JS.
    Oncogene; 2006 Aug 03; 25(33):4559-72. PubMed ID: 16786000
    [Abstract] [Full Text] [Related]

  • 5. Epigenetic regulation of metallothionein-i gene expression: differential regulation of methylated and unmethylated promoters by DNA methyltransferases and methyl CpG binding proteins.
    Majumder S, Kutay H, Datta J, Summers D, Jacob ST, Ghoshal K.
    J Cell Biochem; 2006 Apr 15; 97(6):1300-16. PubMed ID: 16329111
    [Abstract] [Full Text] [Related]

  • 6. Methyl-CpG binding domain proteins and their involvement in the regulation of the MAGE-A1, MAGE-A2, MAGE-A3, and MAGE-A12 gene promoters.
    Wischnewski F, Friese O, Pantel K, Schwarzenbach H.
    Mol Cancer Res; 2007 Jul 15; 5(7):749-59. PubMed ID: 17634428
    [Abstract] [Full Text] [Related]

  • 7. Chromatin composition alterations and the critical role of MeCP2 for epigenetic silencing of progesterone receptor-B gene in endometrial cancers.
    Chu Y, Wang Y, Zhang G, Chen H, Dowdy SC, Xiong Y, Liu F, Zhang R, Li J, Jiang SW.
    Cell Mol Life Sci; 2014 Sep 15; 71(17):3393-408. PubMed ID: 24531693
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Demethylation by 5-aza-2'-deoxycytidine in colorectal cancer cells targets genomic DNA whilst promoter CpG island methylation persists.
    Mossman D, Kim KT, Scott RJ.
    BMC Cancer; 2010 Jul 12; 10():366. PubMed ID: 20618997
    [Abstract] [Full Text] [Related]

  • 10. MDR1 promoter hypermethylation in MCF-7 human breast cancer cells: changes in chromatin structure induced by treatment with 5-Aza-cytidine.
    David GL, Yegnasubramanian S, Kumar A, Marchi VL, De Marzo AM, Lin X, Nelson WG.
    Cancer Biol Ther; 2004 Jun 12; 3(6):540-8. PubMed ID: 15034303
    [Abstract] [Full Text] [Related]

  • 11. Caspase 8 and maspin are downregulated in breast cancer cells due to CpG site promoter methylation.
    Wu Y, Alvarez M, Slamon DJ, Koeffler P, Vadgama JV.
    BMC Cancer; 2010 Feb 04; 10():32. PubMed ID: 20132554
    [Abstract] [Full Text] [Related]

  • 12. Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation.
    Kondo Y, Shen L, Cheng AS, Ahmed S, Boumber Y, Charo C, Yamochi T, Urano T, Furukawa K, Kwabi-Addo B, Gold DL, Sekido Y, Huang TH, Issa JP.
    Nat Genet; 2008 Jun 04; 40(6):741-50. PubMed ID: 18488029
    [Abstract] [Full Text] [Related]

  • 13. Epigenetic regulation of O6-methylguanine-DNA methyltransferase gene expression by histone acetylation and methyl-CpG binding proteins.
    Danam RP, Howell SR, Brent TP, Harris LC.
    Mol Cancer Ther; 2005 Jan 04; 4(1):61-9. PubMed ID: 15657354
    [Abstract] [Full Text] [Related]

  • 14. DNA methylation and histone modifications cause silencing of Wnt antagonist gene in human renal cell carcinoma cell lines.
    Kawamoto K, Hirata H, Kikuno N, Tanaka Y, Nakagawa M, Dahiya R.
    Int J Cancer; 2008 Aug 01; 123(3):535-42. PubMed ID: 18404682
    [Abstract] [Full Text] [Related]

  • 15. Release of methyl CpG binding proteins and histone deacetylase 1 from the Estrogen receptor alpha (ER) promoter upon reactivation in ER-negative human breast cancer cells.
    Sharma D, Blum J, Yang X, Beaulieu N, Macleod AR, Davidson NE.
    Mol Endocrinol; 2005 Jul 01; 19(7):1740-51. PubMed ID: 15746193
    [Abstract] [Full Text] [Related]

  • 16. Epigenetic regulation of the KAI1 metastasis suppressor gene in human prostate cancer cell lines.
    Sekita N, Suzuki H, Ichikawa T, Kito H, Akakura K, Igarashi T, Nakayama T, Watanabe M, Shiraishi T, Toyota M, Yoshie O, Ito H.
    Jpn J Cancer Res; 2001 Sep 01; 92(9):947-51. PubMed ID: 11572762
    [Abstract] [Full Text] [Related]

  • 17. Altered chromatin structure associated with methylation-induced gene silencing in cancer cells: correlation of accessibility, methylation, MeCP2 binding and acetylation.
    Nguyen CT, Gonzales FA, Jones PA.
    Nucleic Acids Res; 2001 Nov 15; 29(22):4598-606. PubMed ID: 11713309
    [Abstract] [Full Text] [Related]

  • 18. Heterogeneity in the modification and involvement of chromatin components of the CpG island of the silenced human CDH1 gene in cancer cells.
    Koizume S, Tachibana K, Sekiya T, Hirohashi S, Shiraishi M.
    Nucleic Acids Res; 2002 Nov 01; 30(21):4770-80. PubMed ID: 12409468
    [Abstract] [Full Text] [Related]

  • 19. Epigenetic modification of TLR4 promotes activation of NF-κB by regulating methyl-CpG-binding domain protein 2 and Sp1 in gastric cancer.
    Kim TW, Lee SJ, Oh BM, Lee H, Uhm TG, Min JK, Park YJ, Yoon SR, Kim BY, Kim JW, Choe YK, Lee HG.
    Oncotarget; 2016 Jan 26; 7(4):4195-209. PubMed ID: 26675260
    [Abstract] [Full Text] [Related]

  • 20. Epigenetic DNA methylation of antioxidative stress regulator NRF2 in human prostate cancer.
    Khor TO, Fuentes F, Shu L, Paredes-Gonzalez X, Yang AY, Liu Y, Smiraglia DJ, Yegnasubramanian S, Nelson WG, Kong AN.
    Cancer Prev Res (Phila); 2014 Dec 26; 7(12):1186-97. PubMed ID: 25266896
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.